202 related articles for article (PubMed ID: 38288611)
1. Unlocking the power of sugar: carbohydrate ligands as key players in nanotherapeutic-assisted targeted cancer therapy.
Swami R; Vij S; Sharma S
Nanomedicine (Lond); 2024 Feb; 19(5):431-453. PubMed ID: 38288611
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Carbohydrate ligands-directed active tumor targeting of combinatorial chemotherapy/phototherapy-based nanomedicine: A review.
Agwa MM; Elmotasem H; Elsayed H; Abdelsattar AS; Omer AM; Gebreel DT; Mohy-Eldin MS; Fouda MMG
Int J Biol Macromol; 2023 Jun; 239():124294. PubMed ID: 37004933
[TBL] [Abstract][Full Text] [Related]
4. A Review on Targeting Nanoparticles for Breast Cancer.
Alqaraghuli HGJ; Kashanian S; Rafipour R
Curr Pharm Biotechnol; 2019; 20(13):1087-1107. PubMed ID: 31364513
[TBL] [Abstract][Full Text] [Related]
5. Carbohydrates based stimulus responsive nanocarriers for cancer-targeted chemotherapy: a review of current practices.
Zhang CW; Zhang JG; Yang X; Du WL; Yu ZL; Lv ZY; Mou XZ
Expert Opin Drug Deliv; 2022 Jun; 19(6):623-640. PubMed ID: 35611662
[TBL] [Abstract][Full Text] [Related]
6. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
[TBL] [Abstract][Full Text] [Related]
7. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
Zhong Y; Meng F; Deng C; Zhong Z
Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476
[TBL] [Abstract][Full Text] [Related]
8. Targeting Sugar Uptake and Metabolism for Cancer Identification and Therapy: An Overview.
Tanasova M; Begoyan VV; Weselinski LJ
Curr Top Med Chem; 2018; 18(6):467-483. PubMed ID: 29788891
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticles and targeted drug delivery in cancer therapy.
Bahrami B; Hojjat-Farsangi M; Mohammadi H; Anvari E; Ghalamfarsa G; Yousefi M; Jadidi-Niaragh F
Immunol Lett; 2017 Oct; 190():64-83. PubMed ID: 28760499
[TBL] [Abstract][Full Text] [Related]
10. Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review.
Muhamad N; Plengsuriyakarn T; Na-Bangchang K
Int J Nanomedicine; 2018; 13():3921-3935. PubMed ID: 30013345
[TBL] [Abstract][Full Text] [Related]
11. A small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapy.
Mou Q; Ma Y; Zhu X; Yan D
J Control Release; 2016 May; 230():34-44. PubMed ID: 27040815
[TBL] [Abstract][Full Text] [Related]
12. Advent in proteins, nucleic acids, and biological cell membranes functionalized nanocarriers to accomplish active or homologous tumor targeting for smart amalgamated chemotherapy/photo-therapy: A review.
Agwa MM; Elmotasem H; Moustafa RI; Abdelsattar AS; Mohy-Eldin MS; Fouda MMG
Int J Biol Macromol; 2023 Dec; 253(Pt 8):127460. PubMed ID: 37866559
[TBL] [Abstract][Full Text] [Related]
13. Ligand-modified Biopolymeric Nanoparticles as Efficient Tools for Targeted Cancer Therapy.
Kouchakzadeh H; Soudi T; Aghda NH; Shojaosadati SA
Curr Pharm Des; 2017; 23(35):5336-5348. PubMed ID: 28552063
[TBL] [Abstract][Full Text] [Related]
14. Influences of different sugar ligands on targeted delivery of liposomes.
Zhang C; Chen Z; Li W; Liu X; Tang S; Jiang L; Li M; Peng H; Lian M
J Drug Target; 2020; 28(7-8):789-801. PubMed ID: 32242754
[TBL] [Abstract][Full Text] [Related]
15. An updated review of folate-functionalized nanocarriers: A promising ligand in cancer.
Ebrahimnejad P; Sodagar Taleghani A; Asare-Addo K; Nokhodchi A
Drug Discov Today; 2022 Feb; 27(2):471-489. PubMed ID: 34781032
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology in cancer therapy.
Aslan B; Ozpolat B; Sood AK; Lopez-Berestein G
J Drug Target; 2013 Dec; 21(10):904-13. PubMed ID: 24079419
[TBL] [Abstract][Full Text] [Related]
17. Polymer decorated gold nanoparticles in nanomedicine conjugates.
Capek I
Adv Colloid Interface Sci; 2017 Nov; 249():386-399. PubMed ID: 28259207
[TBL] [Abstract][Full Text] [Related]
18. An update on dual targeting strategy for cancer treatment.
Taghipour YD; Zarebkohan A; Salehi R; Rahimi F; Torchilin VP; Hamblin MR; Seifalian A
J Control Release; 2022 Sep; 349():67-96. PubMed ID: 35779656
[TBL] [Abstract][Full Text] [Related]
19. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
20. Active drug targeting of disease by nanoparticles functionalized with ligand to folate receptor.
Tu Q; Zhang Y; Liu R; Wang JC; Li L; Nie N; Liu A; Wang L; Liu W; Ren L; Wang X; Wang J
Curr Med Chem; 2012; 19(19):3152-62. PubMed ID: 22612700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
